Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paolo Tarantino, M.D.

Concepts (124)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunoconjugates1920249536.320 Why?
Receptor, erbB-232202425574.770 Why?
Breast Neoplasms422024210193.860 Why?
Antineoplastic Agents132024136421.780 Why?
Neoadjuvant Therapy12202428281.540 Why?
Camptothecin620235911.270 Why?
Cancer Vaccines3202310511.070 Why?
Lung Diseases, Interstitial220239180.880 Why?
Maytansine12022860.800 Why?
Inflammatory Breast Neoplasms120221470.720 Why?
Clinical Trials, Phase I as Topic220243260.670 Why?
Antineoplastic Combined Chemotherapy Protocols132024117420.670 Why?
Neoplasms142024221730.660 Why?
Neoplasm, Residual1202410080.660 Why?
Anthracyclines120212840.650 Why?
Paclitaxel3202417320.610 Why?
Antibiotics, Antineoplastic120216780.580 Why?
Immunotherapy11202446520.570 Why?
Oxazoles320201990.490 Why?
Chemotherapy, Adjuvant5202435140.480 Why?
Female4920243927050.470 Why?
Tumor Burden1202018920.470 Why?
Humans7520247615960.450 Why?
Biological Products120229140.420 Why?
Neoplasm Staging32024111200.410 Why?
Protein Kinase Inhibitors4202456720.410 Why?
Quinazolines3202013710.340 Why?
Pyridines4202428750.340 Why?
Lung Neoplasms32023133810.330 Why?
Carcinoma, Lobular220244810.330 Why?
Urinary Bladder Neoplasms1202122230.320 Why?
Hormones220238690.300 Why?
Carcinoma, Hepatocellular1202022970.290 Why?
Carcinoma, Non-Small-Cell Lung2202353140.290 Why?
Receptors, Estrogen4202422090.280 Why?
Coronavirus Infections2202030860.250 Why?
Pneumonia, Viral2202032060.250 Why?
Prognosis82024296290.250 Why?
Carcinoma, Ductal, Breast2202310850.240 Why?
Liver Neoplasms1202043170.230 Why?
Immunologic Factors3202215900.230 Why?
Quality of Life32022133670.230 Why?
Antibodies, Monoclonal4202091770.220 Why?
Sulfides120221690.190 Why?
Clinical Trials, Phase II as Topic220246290.190 Why?
Pandemics2202086560.180 Why?
Randomized Controlled Trials as Topic42021102120.180 Why?
Receptors, Progesterone2202311290.170 Why?
Immunotoxins120201750.170 Why?
Clinical Trials, Phase III as Topic220218570.170 Why?
Brain Neoplasms1202090320.160 Why?
Thymoma120201880.160 Why?
Genomics3202458210.140 Why?
High-Throughput Nucleotide Sequencing2201936390.130 Why?
Medical Oncology3202423210.130 Why?
Histone Deacetylase Inhibitors120207740.120 Why?
Recombinant Fusion Proteins1202337330.120 Why?
Pharmacogenetics120196750.120 Why?
Neoplasms, Second Primary1202210520.120 Why?
Carcinoma, Intraductal, Noninfiltrating120219260.120 Why?
Clinical Protocols1202014400.110 Why?
Disease-Free Survival1202468150.110 Why?
Neoplasm Recurrence, Local5202492800.110 Why?
Lymphocytes, Tumor-Infiltrating1201910920.110 Why?
Patient Selection2202442440.110 Why?
Hepatitis C1202315840.100 Why?
Biopsy1202467660.100 Why?
Proto-Oncogene Proteins B-raf1202120570.090 Why?
Aged820241693100.090 Why?
Treatment Outcome62024646850.090 Why?
Italy220248420.090 Why?
Kaplan-Meier Estimate1202064840.090 Why?
Drug Resistance, Neoplasm1202453050.080 Why?
Middle Aged820242209210.080 Why?
Data Interpretation, Statistical1201826910.080 Why?
Aged, 80 and over32024589840.080 Why?
Immunohistochemistry12022110760.080 Why?
Adult720242212100.070 Why?
Molecular Targeted Therapy3202428110.070 Why?
Predictive Value of Tests12021152660.060 Why?
Breast2202319670.050 Why?
Adenocarcinoma1202063450.050 Why?
Clinical Trials as Topic1201980020.050 Why?
Melanoma1202157090.050 Why?
Bystander Effect12022900.050 Why?
Young Adult32024592600.050 Why?
Vaccines, Virus-Like Particle12021450.050 Why?
Biology120232900.040 Why?
Vaccines, Subunit120211610.040 Why?
Vaccines, Inactivated120211790.040 Why?
Axilla120236240.040 Why?
Drug Synergism1202417570.040 Why?
Risk Assessment12021239960.040 Why?
Vaccines, Attenuated120213150.040 Why?
Cohort Studies12022414950.040 Why?
Algorithms12020140330.040 Why?
Mutation22021300530.040 Why?
Sentinel Lymph Node Biopsy120237320.040 Why?
Tumor Microenvironment2202238780.040 Why?
Geography120206560.040 Why?
Vaccines, Synthetic120216160.040 Why?
Retrospective Studies52024806470.040 Why?
Diarrhea1202313180.030 Why?
Lymph Node Excision1202312710.030 Why?
Antigens, Neoplasm1202319930.030 Why?
Risk Factors12021742130.030 Why?
MAP Kinase Signaling System1202114860.030 Why?
Piperazines1202425230.030 Why?
Drug Approval120218140.030 Why?
Consensus1202331240.030 Why?
Male520243608460.030 Why?
Infection Control120209820.030 Why?
Diagnostic Tests, Routine120187870.030 Why?
History, 21st Century1201815670.030 Why?
Lymph Nodes1202334650.020 Why?
Drug Prescriptions1202016700.020 Why?
History, 20th Century1201827670.020 Why?
Age Factors12024183990.020 Why?
Prevalence12020157330.010 Why?
Research Design1201861800.010 Why?
Skin Neoplasms1202158210.010 Why?
Disease Progression12018135100.010 Why?
Prospective Studies12023544230.010 Why?
Adolescent12020883260.010 Why?
Tarantino's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (124)
Explore
_
Co-Authors (53)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.